Across TCGA pan-cancer cohorts, GADD45G Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated GADD45G data layer compared with 25 for mass-spec protein.
The strongest signal is observed in lung adenocarcinoma (LUAD), where higher GADD45G Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated GADD45G expression acts as an unfavorable survival marker.
LUAD are the cancer types where GADD45G Mutation most reproducibly stratifies survival.